The paper highlights the potential of AI in the medicinal product lifecycle and the approach that developers should take with it. The European Medicines Agency (EMA) published a draft reflecting paper ...
EMA has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of human and ...
On July 19, the European Medicines Agency (EMA) published a draft reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle. Univadis.com spoke with industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback